Oral Immune-Related Adverse Events Following Durvalumab Administration

Simple item page
dc.contributor.authorRungraungrayabkul D.
dc.contributor.authorOkuma N.
dc.contributor.correspondenceRungraungrayabkul D.
dc.contributor.otherMahidol University
dc.date.accessioned2025-08-13T18:32:55Z
dc.date.available2025-08-13T18:32:55Z
dc.date.issued2025-01-01
dc.identifier.citationOral Diseases (2025)
dc.identifier.doi10.1111/odi.70057
dc.identifier.eissn16010825
dc.identifier.issn1354523X
dc.identifier.scopus2-s2.0-105012458201
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/111581
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.subjectDentistry
dc.titleOral Immune-Related Adverse Events Following Durvalumab Administration
dc.typeLetter
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105012458201&origin=inward
oaire.citation.titleOral Diseases
oairecerif.author.affiliationMahidol University, Faculty of Dentistry

Files

Collections

Scopus 2025